By David Tuller, DrPH Last week I wrote about the recently announced licensing deal between Mahana Therapeutics and King’s College London. The deal involves a web-based course of cognitive behavior therapy designed to treat irritable bowel syndrome. In a major study, the reported improvements in symptoms among participants in the web-based program were modest at …
Trial By Error: My Letter to Professor Moss-Morris Read More »
By David Tuller, DrPH Yesterday I sent a freedom-of-information request to King’s College London about the recently announced licensing deal it has with Mahana Therapeutics. The deal involves a web-based CBT program for irritable bowel syndrome, which I have written about here and here. This morning I sent a note to the e-mail address for …
By David Tuller, DrPH Last October, I gave a talk in Oxford (not AT Oxford) about the dung-heap known as the Lightning Process trial which was published in 2017 in Archives of Disease in Childhood, a BMJ journal. The study’s full name: “Clinical and cost-effectiveness of the Lightning Process in addition to specialist medical care for …
Trial By Error: My Talk Last October in Oxford (Video) Read More »
By David Tuller, DrPH It has been almost two years since BMC Psychology published a key reanalysis of raw data from the PACE trial. Given the significance of this paper (of which I was the least important of seven co-authors), I figured it wouldn’t hurt to highlight it again. The heroic Alem Matthees, a patient …
Trial By Error: The 2018 PACE Reanalysis and the SMC’s Expert Appraisals Read More »
By David Tuller, DrPH Last week I wrote a post on some of the signs used to diagnose people with “functional neurological disorder” (FND)–the phrase that has largely supplanted “conversion disorder” to describe neurological symptoms with no identified organic cause. In that post, I should have been clearer that I do not question whether people …
Trial By Error: Some More Thoughts on Functional Neurological Disorder Read More »
By David Tuller, DrPH One of my goals next year is to write more about so-called “medically unexplained symptoms,” also known as MUS. The term MUS might be useful as a descriptive name for the large category of phenomena that lack a proven pathophysiological pathway. But in the medical literature, and in the minds of …
Trial By Error: Shaky Evidence for Signs of Functional Neurological Disorders Read More »
